🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in users administering substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Several influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Elimination

According to the social media company, the service has taken down violative content and prohibited associated hashtags and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found communities with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, positive testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of entering one community, a seller shared contact information, where the majority of transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, health issues or previous experience.

Product Details and Costs

Inside these groups, messages display dark colored parcels with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to potentially serious health risks”.